home about team portfolio news investor login contact
All Current Investments
Technology
Life Sciences
Exits
Life Sciences
Developing therapeutics for celiac disease
Development-stage biophamaceutical company targeting Huntington's Disease and other hyperkinetic movement disorders
Intracardiac device for the treatment of congestive heart failure
Drug development, focused on Orphan indications in gastroenterology and hepatology
Drug development, focused on bio-better versions of approved biologic drugs
Specialty pharmaceutical company, focused on pediatric neurology
Intra-ocular lens for the treatment of presbyopia
Drug discovery and development, focused on anti-viral indications